middle.news
Imagion Biosystems Advances HER2 Imaging Agent with FDA Backing and $3.5M Raise
9:52am on Tuesday 21st of October, 2025 AEDT
•
Healthcare
Read Story
Imagion Biosystems Advances HER2 Imaging Agent with FDA Backing and $3.5M Raise
9:52am on Tuesday 21st of October, 2025 AEDT
Key Points
Positive FDA feedback supports planned IND filing in Q4 2025
Completed $3.5 million capital raise to fund Phase 2 clinical trial
Collaborations with Wayne State University and Siemens Healthineers to optimize MRI protocols
Manufacturing of MagSense® HER2 imaging agent completed
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Imagion Biosystems (ASX:IBX)
OPEN ARTICLE